Biocon Biologics Limited

Biocon

Biocon Biologics Inks Pact With Sandoz For Sale Of 2 Biosimilar Products In Australia

BY Press Trust of India

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

Biocon Q4 Profit Declines By 4% To Rs 283 Crore

BY Press Trust of India

Following this development Biocon shares fell as much as 8 per cent to hit an intraday low of Rs 362

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

BY Outlook Business Team